Daniel Costa is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Costa is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Deepa Rangachari is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Rangachari is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy.

David Jackman is an Oncologist in Chestnut Hill, Massachusetts. Dr. Jackman is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Mesothelioma. Dr. Jackman is currently accepting new patients.

Michael Rabin is an Oncologist in Boston, Massachusetts. Dr. Rabin is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Lecia Van Dam Sequist is an Oncologist in Waltham, Massachusetts. Dr. Van Dam Sequist is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.

Geoffrey Oxnard is an Oncologist in Boston, Massachusetts. Dr. Oxnard is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy. Dr. Oxnard is currently accepting new patients.

Andris Zauls is a Radiation Oncologist in Brockton, Massachusetts. Dr. Zauls is rated as an Advanced provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Prostate Cancer, Familial Prostate Cancer, and Breast Cancer. Dr. Zauls is currently accepting new patients.

Revati Rao is an Oncologist in Newton, Massachusetts. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma.

Pasi Janne is an Oncologist in Boston, Massachusetts. Dr. Janne is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy. Dr. Janne is currently accepting new patients.

Zofia Piotrowska is an Oncologist and an Infectious Disease provider in Boston, Massachusetts. Dr. Piotrowska is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Piotrowska is currently accepting new patients.

Rebecca Heist is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Heist is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Heist is currently accepting new patients.

Justin Gainor is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Gainor is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Gainor is currently accepting new patients.

Dr. Steven J. Mentzer is a thoracic surgeon at Brigham and Women’s Hospital and Dana-Farber Brigham Cancer Center. He is a professor of surgery at Harvard Medical School.Dr. Mentzer received his medical degree from the University of Minnesota and received his general surgical residency training at the Brigham. He completed a cardiothoracic surgery fellowship at the University of Toronto. Dr. Mentzer also completed a research fellowship at Dana-Farber Cancer Institute where he investigated the molecular mechanisms involved in the regulation of T lymphocyte function. He is board certified in surgery, cardiothoracic surgery, and surgical critical care.Dr. Mentzer’s clinical interests include diseases of the lungs and thoracic cancers, minimally invasive surgery of the lungs and esophagus, and minimally invasive surgery for esophageal cancer. Principal investigator for The Mentzer Lab, Dr. Mentzer is currently studying the adaptive processes involved in blood vessel growth (angiogenesis) and lung regeneration. Dr. Mentzer is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, Gastrostomy, and Endoscopy.

Dr. Jon Wee is the Esophageal Surgery Section Chief, Director of Robotics in Thoracic Surgery, and co-Director of Minimally Invasive Thoracic Surgery at Brigham and Women’s Hospital. He is also an Associate Program Director for Thoracic Surgery and is an Assistant Professor of Surgery at Harvard Medical School.Dr. Wee received his medical degree from the Duke University School of Medicine and completed his surgical training at Brigham and Women’s Hospital. He then went on to complete his cardiothoracic surgery training at the University of Pittsburgh Medical Center. He is board certified in surgery and thoracic surgery.Dr. Wee’s clinical interest is in minimally invasive approaches to thoracic diseases. These include minimally invasive and robotic esophagectomy, lobectomy, thymectomy and mediastinal resection for thoracic malignancies.  In addition, he treats benign esophageal disease such as gastro-esophageal reflux disease, giant paraesophageal hernias, diverticulum, etc. He performs POEM procedures for achalasia as well as sympathectomy for hyperhidrosis and endoluminal therapies such as PDT, laser, and stents for palliation. His research interest is in the use of minimally invasive techniques to decrease pain, improve recovery, and improve ultimate outcomes. Dr. Wee is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Endoscopy, and Thymectomy.

Dr. Wain joined the Brigham in February 2023 as a Surgeon, and Associate Chief of Quality and Safety, both for the Thoracic Surgery Department. Before joining the Brigham, Dr. Wain was the chief of the Division of Thoracic Surgery and the vice chairman of the Department of Surgery at St. Elizabeth’s Medical Center He’s a member of various societies, including the American Thoracic Society, the American College of Chest Physicians, the Society of Thoracic Surgeons and the American Association for Thoracic Surgery. Dr. Wain received his undergraduate degree from Pennsylvania State University and his medical degree from Jefferson Medical College. He completed residency training in surgery at Massachusetts General Hospital. After a surgical research fellowship at the City of Hope National Medical Center, he completed a fellowship in cardiothoracic surgery at Massachusetts General Hospital and Toronto General Hospital. He is certified by the American Board of Surgery and the American Board of Thoracic Surgery. Dr. Wain is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Endoscopy, and Gastrostomy.

Dr. Ciaran McNamee is a thoracic surgeon at Brigham and Women’s Hospital and Dana-Farber Brigham Cancer Center. He is chief of thoracic surgery at Kent Hospital and is an instructor in surgery at Harvard Medical School. Dr. McNamee received his medical degree from McGill University in Canada and completed a surgery residency at University of Alberta Hospital as well as cardiothoracic surgery residencies at Broadgreen Hospital and Royal Devon and Exeter Hospital. He completed a clinical fellowship in thoracic surgery at the University of Manitoba and a research fellowship in thoracic surgery at the University of Alberta. Board certified in surgery and thoracic surgery, Dr. McNamee holds a Fellowship of the Royal College of Surgeons (FRCS). Dr. McNamee's clinical interests include lung cancer, lung cancer screening and esophageal cancer. His research focuses on mutational changes in lung cancer, regional outcome analysis and telemedicine. Dr. McNamee has been listed as one of America’s Top Doctors by Castle Connolly. Dr. Mcnamee is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Gastrostomy, and Advanced Bronchoscopy.

Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy.  He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Michael Kent is a General Surgeon in Boston, Massachusetts. Dr. Kent is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Endoscopy, and Gastrostomy.

Sidharta Gangadharan is a Thoracic Surgeon in Boston, Massachusetts. Dr. Gangadharan is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Tracheobronchomalacia, Acquired Tracheomalacia, Lung Nodules, Endoscopy, and Gastrectomy.